At last week’s American Chemical Society Spring meeting, Bristol Myers Squibb Co. discussed the development of a potent, orally bioavailable and highly selective cereblon (CRBN)-mediated ...

With its stock down 25% over the past three months, it is easy to disregard Corbion (AMS:CRBN). However, stock prices are usually driven by a company’s financials over the long term, which in ...

Corbion N.V. (AMS:CRBN) will increase its dividend from last year's comparable payment on the 27th of May to €0.64. This makes the dividend yield about the same as the industry average at 3.4%.